Scientists test new psoriasis Pill's effect on contraception
NCT ID NCT07181343
Summary
This early-stage study aimed to see if a new oral drug for psoriasis (HS-10374) changes how the body processes a common birth control pill (Yasmin). It involved 18 healthy female volunteers who took both medications in a set sequence. The main goal was to measure drug levels in the blood to check for any safety concerns from mixing the two pills.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS (PSO) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Affiliated Hospital of Qingdao University
Qingdao, Shandong, 266001, China
Conditions
Explore the condition pages connected to this study.